Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

Are these investors still here?

On March 28, 2017, Cellceutix Corporation (the “Company”) entered into stock purchase agreements (the “Stock Purchase Agreements”) with certain investors, pursuant to which the Company agreed to sell 2,471,912 shares of its Class A common stock at $0.89 per share in a registered direct offering (the “Offering”), without an underwriter or placement agent. The Offering closed on March 31, 2017. Net proceeds to the Company from the Offering were approximately $2.2 million after deducting anticipated transaction expenses of approximately $12,000. The Company intends to use the net proceeds from the Offering for general corporate purposes.

Do they still believe in Leo Ehrlich?